JG
ADPT icon

Jain Global’s Adaptive Biotechnologies ADPT Stock Holding History

Jain Global’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$426K Buy
+19,846
New +$304K ﹤0.01% 1253

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jain Global's ADPT Position: Q2 2026 in Review

Jain Global opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 19,846 shares worth $426K. The stake represents ﹤0.01% of the portfolio and ranks #1253 among its holdings.

300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Jain Global held 19,846 shares of Adaptive Biotechnologies worth $426K as of Q2 2026.
  • Adaptive Biotechnologies was a new Jain Global position in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1253 holding.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.